Dear Ms. Summers and Dr. Rosenfeld,
The undersigned organizations are writing to request that the Association for the Accreditation of Human Research Protection Programs (AAHRPP) consider updating its accreditation guidelines and resources (for Institutional Review Boards (IRBs) seeking accreditation or accreditation renewal) to include information addressing issues of access to, and representation in, clinical trials for all individuals impacted by a specific disease.
Read the Full Letter